886 related articles for article (PubMed ID: 25097095)
1. Adverse effects of androgen deprivation therapy and strategies to mitigate them.
Nguyen PL; Alibhai SM; Basaria S; D'Amico AV; Kantoff PW; Keating NL; Penson DF; Rosario DJ; Tombal B; Smith MR
Eur Urol; 2015 May; 67(5):825-36. PubMed ID: 25097095
[TBL] [Abstract][Full Text] [Related]
2. Side effects of androgen deprivation therapy: monitoring and minimizing toxicity.
Higano CS
Urology; 2003 Feb; 61(2 Suppl 1):32-8. PubMed ID: 12667885
[TBL] [Abstract][Full Text] [Related]
3. Androgen deprivation therapy: evidence-based management of side effects.
Ahmadi H; Daneshmand S
BJU Int; 2013 Apr; 111(4):543-8. PubMed ID: 23351025
[TBL] [Abstract][Full Text] [Related]
4. Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis.
Shahani S; Braga-Basaria M; Basaria S
J Clin Endocrinol Metab; 2008 Jun; 93(6):2042-9. PubMed ID: 18349064
[TBL] [Abstract][Full Text] [Related]
5. Androgen deprivation therapy impact on quality of life and cardiovascular health, monitoring therapeutic replacement.
Trost LW; Serefoglu E; Gokce A; Linder BJ; Sartor AO; Hellstrom WJ
J Sex Med; 2013 Feb; 10 Suppl 1():84-101. PubMed ID: 23387914
[TBL] [Abstract][Full Text] [Related]
6. Complications of androgen-deprivation therapy for prostate cancer.
Holzbeierlein JM; Castle EP; Thrasher JB
Clin Prostate Cancer; 2003 Dec; 2(3):147-52. PubMed ID: 15040857
[TBL] [Abstract][Full Text] [Related]
7. Androgen deprivation therapy in prostate cancer: anticipated side-effects and their management.
Kim HS; Freedland SJ
Curr Opin Support Palliat Care; 2010 Sep; 4(3):147-52. PubMed ID: 20592607
[TBL] [Abstract][Full Text] [Related]
8. Management of complications of androgen deprivation therapy in the older man.
Mohile SG; Mustian K; Bylow K; Hall W; Dale W
Crit Rev Oncol Hematol; 2009 Jun; 70(3):235-55. PubMed ID: 18952456
[TBL] [Abstract][Full Text] [Related]
9. Lifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an update.
Owen PJ; Daly RM; Livingston PM; Fraser SF
Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):137-145. PubMed ID: 28117386
[TBL] [Abstract][Full Text] [Related]
10. Androgen deprivation therapy-associated vasomotor symptoms.
Jones JM; Kohli M; Loprinzi CL
Asian J Androl; 2012 Mar; 14(2):193-7. PubMed ID: 22286861
[TBL] [Abstract][Full Text] [Related]
11. Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer.
Taylor LG; Canfield SE; Du XL
Cancer; 2009 Jun; 115(11):2388-99. PubMed ID: 19399748
[TBL] [Abstract][Full Text] [Related]
12. Androgen deprivation therapy and estrogen deficiency induced adverse effects in the treatment of prostate cancer.
Freedland SJ; Eastham J; Shore N
Prostate Cancer Prostatic Dis; 2009; 12(4):333-8. PubMed ID: 19901933
[TBL] [Abstract][Full Text] [Related]
13. Androgen deprivation therapy in men with prostate cancer: how should the side effects be monitored and treated?
Grossmann M; Zajac JD
Clin Endocrinol (Oxf); 2011 Mar; 74(3):289-93. PubMed ID: 21092052
[TBL] [Abstract][Full Text] [Related]
14. Management of Androgen Deprivation Therapy-Associated Hot Flashes in Men With Prostate Cancer.
Qan'ir Y; DeDeaux D; Godley PA; Mayer DK; Song L
Oncol Nurs Forum; 2019 Jul; 46(4):E107-E118. PubMed ID: 31225840
[TBL] [Abstract][Full Text] [Related]
15. Complications of androgen deprivation therapy in men with prostate cancer.
Chen AC; Petrylak DP
Curr Oncol Rep; 2004 May; 6(3):209-15. PubMed ID: 15066232
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular and Metabolic Effects of Androgen-Deprivation Therapy for Prostate Cancer.
Gupta D; Lee Chuy K; Yang JC; Bates M; Lombardo M; Steingart RM
J Oncol Pract; 2018 Oct; 14(10):580-587. PubMed ID: 30312560
[TBL] [Abstract][Full Text] [Related]
17. Complications of androgen-deprivation therapy in men with prostate cancer.
Chen AC; Petrylak DP
Curr Urol Rep; 2005 May; 6(3):210-6. PubMed ID: 15869725
[TBL] [Abstract][Full Text] [Related]
18. Andropause syndrome in men treated for metastatic prostate cancer: a qualitative study of the impact of symptoms.
Grunfeld EA; Halliday A; Martin P; Drudge-Coates L
Cancer Nurs; 2012; 35(1):63-9. PubMed ID: 21558849
[TBL] [Abstract][Full Text] [Related]
19. Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth.
Basaria S
J Androl; 2008; 29(5):534-9. PubMed ID: 18567642
[TBL] [Abstract][Full Text] [Related]
20. Androgen deprivation therapy complications.
Allan CA; Collins VR; Frydenberg M; McLachlan RI; Matthiesson KL
Endocr Relat Cancer; 2014 Aug; 21(4):T119-29. PubMed ID: 24872511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
